Skip to Content

Clinical Trials Search Results

Showing 1-10 of 23

Sorted By:

  • A081105

    Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)

  • ACCRU RU011201I

    A Randomized Phase III Trial of Eribulin Compared to Standard Weekly Paclitaxel as First- or Second-Line Therapy for Locally Recurrent or Metastatic Breast Cancer.

  • Alliance A031201

    Phrase III trial of Enzalutamide versus Enzalutamide, Abiraterone, and Prednisone for Castration Resistant Metastatic Prostate Cancer

  • Alliance A151216

    Genetic Testing For Patients with Resectable or Resected Lung Cancer

  • Amgen 20120171

    Prospective, Observational Study to Determine Physician-assessed Clinical Considerations for Packed Red Blood Cell Transfusions in Subjects with Hemoglobin > 7 g/dL and < 10 g/Dl

  • CA204143

    An expanded Access Program for Leotuzumab in Combination with Lenalidomide plus Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma

  • CALGB 80702

    A Phase III Trial of 6 Versus 12 Treatments of Adjuvant FOLFOX Plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer

  • CTSU E1A11

    Randomized Phase III Trial of Bortezomib, LENalidomide and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide and Dexamethasone (CRd) Followed by Limited or Indefinite DURation Lenalidomide MaintenANCE in Patients with Newly Diagnosed Symptomatic Multiple Myeloma (ENDURANCE)

  • CTSU/ECOG E2810

    Randomized, Double-Blind Phase III Study of Pazopanib vs. Placebo in Patients with Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease Following Metastatectomy

  • D4191C00001 PACIFIC

    A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-centre, International Study of MEDI4736 as Sequential Therapy in Patients with Locally Advanced, Unresectable Non-Small Cell Lung Cancer (Stage III) Who Have Not Progressed Following Definitive, Platinum-based, Concurrent Chemo radiation Therapy.

Page of 3, showing trials 1-10 of 23

Also in this Section